<DOC>
	<DOCNO>NCT02018991</DOCNO>
	<brief_summary>The polymer release drug first-generation drug-eluting stent ( DES ) may induce allergic reaction inflammation , result late-acquired stent malaposition ( LASM ) uncoverage strut , risk stent thrombosis . The incidence predictor LASM DES newer-generation polymer design improve biocompatibility unknown .</brief_summary>
	<brief_title>Late Acquired Malaposition Different Polymers</brief_title>
	<detailed_description>please see brief summary</detailed_description>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Patients underwent elective treatment coronary lesion &gt; 20mm DES chronic renal failure ( serum creatinine â‰¥ 2.5mg/dl ) restenotic lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>